| Financial Year |
March 31 2023 |
| Monetary Funds |
33,763,424.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,668,627.06 |
| Accounts Receivable |
29,395,735.57 |
| Advances to Suppliers |
6,351,380.50 |
| Other Receivables |
1,532,073.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,607,745.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
615,185.54 |
| Total Current Assets |
115,233,546.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
123,310,698.89 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,885,921.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
87.50 |
| Other Non-Current Assets |
4,571,520.00 |
| Sub-Total of Non-Current Assets |
134,444,296.49 |
| Total Assets |
249,677,842.89 |
| Short-Term Loans |
36,600,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,613,342.54 |
| Accounts Payable |
64,397,592.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,788,179.00 |
| Taxes Payable |
865,768.28 |
| Interest Payable |
256,616.45 |
| Dividend Payable |
-- |
| Other payables |
32,435,736.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
3,995,129.26 |
| Sub-Total of Current Liabilities |
152,695,748.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,572,670.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,572,670.08 |
| Total Liabilities |
154,268,418.69 |
| Paid-In Capital(Or Share Stock) |
262,055,378.00 |
| Capital Surplus |
296,359,492.98 |
| Surplus Reserve |
22,677,057.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-471,724,284.79 |
| Minority Stockholder's Interest |
1,590,712.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
93,818,712.13 |
| Owner's Equity（Stockholder's Equity） |
95,409,424.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
249,677,842.89 |
